NCT05901285
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05901285
Title Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Vaxiion Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center RECRUITING Tucson Arizona 85719 United States Details
Sarah Cannon Research Institute at HealthONE RECRUITING Denver Colorado 80218 United States Details
George Washington University RECRUITING Washington D.C. District of Columbia 20052 United States Details
University of Maryland RECRUITING Baltimore Maryland 21201 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Dartmouth Cancer Center RECRUITING Lebanon New Hampshire 03756 United States Details
Atlantic Health System RECRUITING Morristown New Jersey 07960 United States Details
Cleveland Clinic RECRUITING Cleveland Ohio 44195 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field